Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK
Novo Nordisk A/S Approval is based on results from the OASIS 4 trial, which investigated semaglutide tablets 25…
Browsing Tag